Vigabatrin in childhood epilepsy: Comparable efficacy for generalized and partial seizures

Clinical Neuropharmacology

Volumn 19, Issue 4, 1996, Pages 297-304

  Sheth, Raj D ^a,c   Buckley, David ^a   Penney, Sharon ^a   Hobbs, Gerald R ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Child; Epilepsy; Refractory; Seizures; Vigabatrin

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETHOSUXIMIDE; NITRAZEPAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; AGITATION; ARTICLE; ATAXIA; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; MALE; PRIORITY JOURNAL; SOMNOLENCE; TUBEROUS SCLEROSIS; VERTIGO;

EID: 0030008737     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619040-00002     Document Type: Article

References (30)

1. Sarhan S, Seiler N. Metabolic inhibitors and subcelluar distribution of GABA. J Neurosci Res 1979;4:399-421.
2. Gale K. GABA and epilepsy: basic concepts from preclinical research. Epilepsia 1992;33:S3-12.
3. Shin C, Rigsbee LC, McNamara JO. Anti-seizure and anti-epileptogenic effect of gamma-vinyl gamma-aminobutyric acid in amygdaloid kindling. Brain Res 1986;398:370-4.
4. Loscher W, Czuczwar SJ, Jackel R, Schwarz M. Effects of microinjections of gamma-vinyl GABA or isoniazid into substantia nigra on the development of amygadala kindling in rats. Exp Neurol 1987;95:622-38.
5. Browne TR, Mattson RH, Penry JK, et al. Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: an update. Neurology 1991;41:363-4.
6. Cocito L, Maffini M, Perfumo P, Roncallo F, Loeb C. Vigabatrin in complex partial seizures: a long-term study. Epilepsy Res 1989;3:160-6.
7. Gram L, Sabers A, Dulac O. Treatment of pediatric epilepsies with gamma-vinyl GABA (vigabatrin). Epilepsia 1992;33:526-9.
8. Herranz JL, Arteaga R, Farr IN, Valdizan E, Beaumont D, Armijo JA. Dose-response study of vigabatrin in children with refractory epilepsy. J Child Neurol 1991;suppl 2:S45-51.
9. Tartara A, Manni R, Galimberti CA, et al. Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. Acta Neurol Scand 1992;86:247-51.
10. Tassinari CA, Michelucci R, Ambrosetto G, Salvi F. Double-blind study of vigabatrin in the treatment of drug-resistant epilepsy. Arch Neurol 1987;44:907-10.
11. Dulac O, Chiron C, Luna D, et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991;suppl 2:S30-7.
12. Mumford JP, Dam M. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 1989;27:1018-78.
13. Reynolds EH, Ring HA, Farr IN, Heller AJ, Elwes RD. Open, double-blind and long-term study of vigabatrin in chronic epilepsy. Epilepsia 1991;32:530-8.
14. Livingston JH, Beaumont D, Arzimanoglou A, Aicardi J. Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 1989;27:109S-12S.
15. Luna D, Dulac O, Pajot N, Beaumont D. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study. Epilepsia 1989;30:430-7.
16. Feucht M, Brantner Inthaler S. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study. Epilepsia 1994;35:993-8.
17. Curatolo P. Vigabatrin for refractory partial seizures in children with tuberous sclerosis. Neuropediatrics 1994;25:55.
18. Armijo JA, Arteaga R, Valdizan EM, Herranz JL. Coadministration of vigabatrin and valproate in children with refractory epilepsy. Clin Neuropharmacol 1992;15:459-69.
19. Chiron C, Dulac O, Beaumont D, Palacios L, Pajot N, Mumford J. Therapeutic trial of vigabatrin in refractory infantile spasms. J Child Neurol 1991;suppl 2:S52-9.
20. Appleton RE. The role of vigabatrin in the management of infantile epileptic syndromes. Neurology 1993;43:S21-3.
21. Graham D. Neuropathology of vigabatrin. Br J Clin Pharmacol 1989;27:43S-5S.
22. Reynolds EH. Gamma-vinyl GABA (vigabatrin): clinical experience in adult and adolescent patients with intractable epilepsy. Epilepsia 1992;33:830-4.
23. Cocito L, Maffini M, Loeb C. MRI findings in epileptic patients on vigabatrin for more than 5 years. Seizure 1992;1:163-5.
24. Kalviainen R, Aikia M, Partanen J, et al. Randomized controlled pilot study of vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy: an interim report. J Child Neurol 1991;6:2860-9.
25. Connelly JF. Vigabatrin. Ann Pharmacother 1993;27:197-204.
26. Kurland AH, Browne TR. Vigabatrin (Sabril). Clin Neuropharmacol 1994;17:560-8.
27. Sharief MK, Sander JW, Shorvon SD. Acute encephalopathy with vigabatrin. Lancet 1993;342:619.
28. Aldenkamp AP, Vermeulen J, Mulder OG, et al. Gamma-vinyl GABA (vigabatrin) and mood disturbances. Epilepsia 1994;35:999-1004.
29. Dam M. Vigabatrin and behaviour disturbances. Lancet 1990;335:605.
30. Sheth RD, Goulden KJ, Ronen GM. Aggression in children treated with clobazam for epilepsy. Clin Neuropharmacol 1994;17:332-7.